chr19-3595704-C-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001060.6(TBXA2R):​c.1016G>C​(p.Arg339Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000503 in 1,590,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000035 ( 0 hom. )

Consequence

TBXA2R
NM_001060.6 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.21
Variant links:
Genes affected
TBXA2R (HGNC:11608): (thromboxane A2 receptor) This gene encodes a member of the G protein-coupled receptor family. The protein interacts with thromboxane A2 to induce platelet aggregation and regulate hemostasis. A mutation in this gene results in a bleeding disorder. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08942169).
BS2
High AC in GnomAdExome4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBXA2RNM_001060.6 linkc.1016G>C p.Arg339Pro missense_variant Exon 3 of 3 ENST00000375190.10 NP_001051.1 P21731-3Q05C92Q0VAB0
TBXA2RXM_011528214.3 linkc.1016G>C p.Arg339Pro missense_variant Exon 4 of 4 XP_011526516.1 P21731-3
TBXA2RNM_201636.3 linkc.983+33G>C intron_variant Intron 3 of 3 NP_963998.2 P21731-2Q05C92Q0VAB0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBXA2RENST00000375190.10 linkc.1016G>C p.Arg339Pro missense_variant Exon 3 of 3 1 NM_001060.6 ENSP00000364336.4 P21731-3
TBXA2RENST00000589966.1 linkc.627G>C p.Ala209Ala synonymous_variant Exon 2 of 2 1 ENSP00000468145.1 K7ER80
TBXA2RENST00000411851.3 linkc.983+33G>C intron_variant Intron 3 of 3 2 ENSP00000393333.2 P21731-2

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152226
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000977
AC:
2
AN:
204756
Hom.:
0
AF XY:
0.00000900
AC XY:
1
AN XY:
111052
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000684
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000348
AC:
5
AN:
1438312
Hom.:
0
Cov.:
66
AF XY:
0.00000281
AC XY:
2
AN XY:
712956
show subpopulations
Gnomad4 AFR exome
AF:
0.0000901
Gnomad4 AMR exome
AF:
0.0000498
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152226
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74364
show subpopulations
Gnomad4 AFR
AF:
0.0000724
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Dec 07, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1016G>C (p.R339P) alteration is located in exon 3 (coding exon 2) of the TBXA2R gene. This alteration results from a G to C substitution at nucleotide position 1016, causing the arginine (R) at amino acid position 339 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
12
DANN
Benign
0.92
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.062
N
LIST_S2
Benign
0.50
T
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.089
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L
PROVEAN
Benign
0.42
N
REVEL
Benign
0.018
Sift
Uncertain
0.028
D
Sift4G
Benign
0.28
T
Polyphen
0.41
B
Vest4
0.068
MutPred
0.25
Loss of MoRF binding (P = 3e-04);
MVP
0.53
ClinPred
0.052
T
GERP RS
2.4
Varity_R
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs563919263; hg19: chr19-3595702; API